Apex Biotechnology Corp. (TPE:1733)
Taiwan
· Delayed Price · Currency is TWD 28.50
-0.90 (-3.06%)
At close: Mar 9, 2026
Apex Biotechnology Revenue
Apex Biotechnology had revenue of 437.21M TWD in the quarter ending September 30, 2025, a decrease of -14.20%. This brings the company's revenue in the last twelve months to 1.96B, up 8.38% year-over-year. In the year 2024, Apex Biotechnology had annual revenue of 1.85B with 10.48% growth.
Revenue (ttm)
1.96B
Revenue Growth
+8.38%
P/S Ratio
1.45
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.85B | 175.67M | 10.48% |
| Dec 31, 2023 | 1.68B | -567.64M | -25.29% |
| Dec 31, 2022 | 2.24B | 112.52M | 5.28% |
| Dec 31, 2021 | 2.13B | 126.32M | 6.30% |
| Dec 31, 2020 | 2.01B | -193.53M | -8.80% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| 3D Global Biotech | 324.87M |
| Syngen Biotech | 2.14B |
| GlycoNex Incorporation | 36.63M |
| SYN-TECH Chem. & Pharm. | 1.30B |
| Intech Biopharm | 113.85M |
| Sunny Pharmtech | 290.18M |
| Synbio Tech | 1.00B |
| BRIM Biotechnology | 3.17M |